Agents for Parenteral Antibiotic Treatment of CSF Shunt Infections
Isolated Microorganism | First-line antibiotics | Other choices |
Staphylococcus epidermidis | Vancomycin, linezolid | Oxacillin, nafcillin |
Staphylococcus aureus | Vancomycin, linezolid | Oxacillin, nafcillin |
Enterococcus faecalis | Vancomycin, penicillin | Ampicillin |
Escherichia coli | Cefotaxime, meropenem | Gentamycin, amikacin |
Klebsiella pneumoniae | Cefotaxime, meropenem | Gentamycin, amikacin |
Proteus sp. | Cefotaxime, ceftazidime | Gentamycin, amikacin |
Pseudomonas sp. | Ceftazidime + amikacin | Meropenem, cefipime |
Haemophilus influenzae | Cefotaxime, ampicillin | Ceftriaxone |
Streptococcus pneumoniae | Penicillin G, cefotaxime, ceftriaxone | Vancomycin, ampicillin |
Neisseria meningitidis | Penicillin G, ampicillin | Cefotaxime, ceftriaxone |
Propionibacterium acnes | Penicillin G | Doxycycline |
Corynebacterium sp. | Penicillin G | Doxycycline |
Candida sp. | Amphotericin B | Caspofungine, voriconazole |
Agents for Intraventricular Treatment of CSF Shunt Infections
Antimicrobial Agent | Dose |
Gentamycin | 2–8 mg/day |
Vancomycin | 4–20 mg/day |
Amphotericin B | 0.1–0.5 mg/day |
Miconazole | 20 mg/day |
Modified from Kaufman (89)
Please create a free account or log in to read 'Antibiotic Choices for Infecting Organisms of Shunt Infections in Children'
Registration is free, quick and easy. Register and complete your profile and get access to the following:
- Full unrestricted access to The ISPN Guide
- Download pages as PDFs for offline viewing
- Create and manage page bookmarks
- Access to new and improved on-page references